The sales are trivial relative to market cap and follow a June 29 equity grant, consistent with tax-covering or liquidity sales. The CEO's larger $116K sale on the same day reinforces a pattern of grant-and-sell. No bearish signal — monitor upcoming clinical data readouts for the real catalyst.
Price Chart
Executive Summary
Two C-suite insiders (COO and CFO) at Lexeo Therapeutics sold a combined ~$42K in open-market sales on July 1, 2026, immediately following a June 29 equity grant that awarded them shares at $0. The sales are small in absolute terms (~0.01% of market cap) and follow a pattern of grant-and-sell that is consistent with tax planning or liquidity, not a bearish signal.
Key Financial Metrics
Key Facts
- COO Otero sold 4,666 shares at $4.48 for ~$21K on July 1, 2026
- CFO Tamayo sold 4,641 shares at $4.49 for ~$21K on July 1, 2026
- Total open-market sales: ~$42K, or ~0.01% of $366M market cap
- Both executives received equity grants (non-cash) on June 29, 2026 — COO 12,060 shares, CFO 12,000 shares
- CEO Townsend also sold 25,947 shares for ~$116K on July 1, 2026 (separate filing)
- No open-market purchases in the cluster window
Financial Impact
Total open-market sales of ~$42K by COO and CFO, plus CEO sold ~$116K separately — combined ~$158K, or ~0.04% of $366M market cap
Risk Factors
- Clinical-stage biotech with no approved products — pipeline setbacks could cause significant downside
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-LXEO-1782946851399 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | SC 13G | $2.74 $3.02 | ▲ +10.22% | ▲ +11.37% | $2.68 (−2.19%) |
Sep 22, 2026 4w ago | 8-K | $4.07 $3.42 | ▼ −15.97% | ▼ −14.78% | $2.68 (−34.15%) |
Aug 12, 2026 10w ago | 8-K | $4.87 $5.37 | ▲ +10.27% | ▲ +10.71% | $2.68 (−44.97%) |
Aug 12, 2026 10w ago | Press Release | $4.87 $5.37 | ▲ +10.27% | ▲ +10.71% | $2.68 (−44.97%) |
Jul 1, 2026 16w ago | Insider Cluster | $4.69 $5.05 | ▲ +7.68% | ▲ +6.75% | $2.68 (−42.86%) |
Jun 17, 2026 18w ago | Press Release | $4.93 $4.70 | ▼ −4.67% | ▼ −3.00% | $2.68 (−45.64%) |
Jun 15, 2026 19w ago | 8-K | $4.65 $5.04 | ▲ +8.39% | ▲ +9.77% | $2.68 (−42.37%) |
Jun 12, 2026 19w ago | Institutional Cluster | $4.37 $4.93 | ▲ +12.81% | ▲ +12.14% | $2.68 (−38.67%) |
May 20, 2026 22w ago | Insider Cluster | $5.23 $5.14 | ▼ −1.72% | ▼ −3.57% | $2.68 (−48.76%) |
May 11, 2026 24w ago | 8-K | $6.12 $4.71 | ▼ −23.04% | ▼ −22.95% | $2.68 (−56.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers